4.5 Review

Gelatin as Biomaterial for Tissue Engineering

Journal

CURRENT PHARMACEUTICAL DESIGN
Volume 23, Issue 24, Pages 3567-3584

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867324666170511123101

Keywords

Biomaterial; gelatin; 3D scaffolds; tissue engineering; regenerative medicine; particles; bone

Funding

  1. University of the Basque Country UPV/EHU [UFI 11/32]
  2. Basque Country Government [IT907-16]
  3. Ministry of Science and Innovation
  4. Basque Country Government (Departamento de Educacion, Universidades e Investigacion)

Ask authors/readers for more resources

Tissue engineering is considered one of the most important therapeutic strategies of regenerative medicine. The main objective of these new technologies is the development of substitutes made with biomaterials that are able to heal, repair or regenerate injured or diseased tissues and organs. These constructs seek to unlock the limited ability of human tissues and organs to regenerate. In this review, we highlight the convenient intrinsic properties of gelatin for the design and development of advanced systems for tissue engineering. Gelatin is a natural origin protein derived from collagen hydrolysis. We outline herein a state of the art of gelatin-based composites in order to overcome limitations of this polymeric material and modulate the properties of the formulations. Control release of bioactive molecules, formulations with conductive properties or systems with improved mechanical properties can be obtained using gelatin composites. Many studies have found that the use of calcium phosphate ceramics and diverse synthetic polymers in combination with gelatin improve the mechanical properties of the structures. On the other hand, polyaniline and carbon-based nanosubstrates are interesting molecules to provide gelatin-based systems with conductive properties, especially for cardiac and nerve tissue engineering. Finally, this review provides an overview of the different types of gelatin-based structures including nanoparticles, microparticles, 3D scaffolds, electrospun nanofibers and in situ gelling formulations. Thanks to the significant progress that has already been made, along with others that will be achieved in a near future, the safe and effective clinical implementation of gelatin-based products is expected to accelerate and expand shortly.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available